echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Production Process of B-[3-[(Butylamino)sulfonyl]phenyl]boronic acid

    The Production Process of B-[3-[(Butylamino)sulfonyl]phenyl]boronic acid

    • Last Update: 2023-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The production process of B-[3-[(Butylamino)sulfonyl]phenyl]boronic acid involves several steps, which are carried out in a controlled environment to ensure the purity and quality of the final product.
    The production process can be broken down into the following steps:


    1. Synthesis of [3-[(Butylamino)sulfonyl]phenyl]boronic acid: The first step in the production process is the synthesis of [3-[(Butylamino)sulfonyl]phenyl]boronic acid.
      This involves reacting 3-[(butylamino)sulfonyl]phenol with boric acid in the presence of a catalyst, such as hydrochloric acid.
      The reaction is carried out at a temperature of around 100-150°C and the product is isolated by precipitation with a polar solvent, such as ethanol.
    2. Purification of the synthesized compound: The synthesized compound is then purified by recrystallization, which involves dissolving the compound in a suitable solvent, such as ethanol, and allowing it to recrystallize.
      The pure crystals are then collected and dried, and the solvent is removed by evaporation.
    3. Characterization of the purified compound: The purified compound is then characterized using various techniques, such as spectroscopy and chromatography, to determine its chemical composition and identity.
    4. Formulation of the final product: The final step in the production process is the formulation of the B-[3-[(Butylamino)sulfonyl]phenyl]boronic acid.
      This involves mixing the purified compound with a suitable excipient, such as a carrier or a stabilizer, to create a stable and homogeneous solution.
      The formulation is then packaged in appropriate containers, such as vials or bottles, and labeled with relevant information, such as the dosage and storage instructions.
    5. Quality control: The final product is then subjected to quality control tests, such as appearance, pH, and chemical analysis, to ensure that it meets the required standards for purity, potency, and stability.
      The results of these tests are documented and archived, and any deviations from the specified standards are reported and addressed.

    In summary, the production process of B-[3-[(Butylamino)sulfonyl]phenyl]boronic acid involves several steps, including synthesis, purification, characterization, formulation, and quality control.
    Each step must be carried out in a controlled environment and with appropriate equipment to ensure the purity and quality of the final product.
    The production of pharmaceuticals involves strict regulations and standards, and the production process must be designed and implemented to meet these requirements.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.